SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Genetics in Medicine, the ...
The research represents a major step forward in revealing how the three dimensional form of DNA shapes the way human biology functions. In a major step toward understanding how the physical form of ...
Genetic mutations in human DNA can prevent proteins that perform important functions in the body from being formed correctly. This can lead to serious disorders that cause disease or even disability.
Hosted on MSN
GeneDx raises 2025 revenue guidance to $428M amid accelerating exome and genome test growth
GeneDx raised full year 2025 total revenue guidance to $425 million to $428 million. Exome and genome revenue guidance was increased to $358 million to $361 million, reflecting 53% to 55% growth for ...
Management raised full-year 2025 total revenue guidance to $400 million–$415 million and exome/genome revenue growth guidance to 48%–52%, with expected exome and ...
Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guides" has been added to ResearchAndMarkets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback